Member Info for Gareth3672

Read all the messages below the BBC editorial on TCG. “It’s business as usual and we are NOT going in the any form of administration despite what some sectors of the media would have you believe”. Strong buy!

https://www.bbc.co.uk/news/amp/business-48336449

It’s not obvious that it’s a sell, there is a 9p in there after hours and a 12p aswell, all within the space of 45 mins, as a fact, no one can be sure what it is. Likely we will see a few RNS’s soon with TR1s coming through.

Huge profits are not made on “safe bets”, share price is rock bottom in my opinion, back in the teens this week, any bit of positive news will have shorters caught out.

Fosun have increased their percentage to 18% now, what amazes me is that Fosuns major advisor is CITI, now why would CITI suggest TCG were worthless and then have Fosun mop up even more shares? To suggest TCG is only worth 180 million is mental, they have 600 million cash in the bank and over 3 billion in assets. When this starts to go back up it’s gonna be mighty fast as shorts will be covered just before they close.

People saying, carnage, 5p, quoting other stocks that have gone into administration, none of you are shouting from the hills though that it’s most likely the hedge funds which are shorting TCG because I expect most of the posters over the last week are working in conjunction with the hedge funds as well as CITI to get the price down as far as they can so that Fosun can get in on the cheap and then the hedge funds will let it rise up again and it’s all at the detriment of the PI... scandalous. I do hope shorters get there fingers burnt.

Fosun, the Chinese owner of Club Med, has been steadily increasing its stake in Thomas Cook, which now stands at over 18%.

MorningtonOz, nice to hear they are normally very busy and we’re just having a free two minutes off as you walked past.

Market Makers clearly not wanting to let this drop much below 9p, graph looking extremely strong with multiple block buyers today.

The Lupuzorâ open label extension study, initially announced on 18 January 2018, has completed enrolment with a total of 62 eligible patients from the original Phase III trial, who were recruited throughout the US and Europe. The study is anticipated to report results in Q2 2019.

Well if they are expected to report antisipated result in Q2 (1st april to 30th of June) then pehaps we are getting very close to hearing something?

Pokerchips, you could be right, but whilst not a religous man, I do like candle sticks and I especially like the ones that last 10 days.

Trion, agree with you there, silly statement with no facts ... best not use the 10p subject line as thats the only reason its been chosen, to try and flood the board with responses with that as the headline.

Totally understand RX, I sold a small amount yesterday at 60:40p as I had bought some recently at 56p trying to reduce my average, if it drops below 56p ill buy more, likewise if it holds above 60p for more than 3 days I will also add to my existing holding.

Share price has certainly found a decent base, now starting to hold above the "RX" 60p mark, 7 director buys just this month, 4 analysts are now predicting 142p mean target in the next 12 months. Things are moving here at it appears the way is up.

JL5006, LB now has over 200,000 shares so the latest 30k is a welcome purchase. Thats 7 of 9 directors that have made a purchase this month, not something to be sniffed at.

Nice buy...

RNS

If we can hold 61.35.. next stop 67p

and what a deeeep handle that was so would like to think we will continue this rise now pushing 70p +

Theres your 60p RX... hopefully it will hold for us both.